IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 301 - 320 of 1046 stories.
October 16, 2012
Frutarom Industries (Haifa, Israel) is building a new R&D center and manufacturing plant for flavors and fragrances at Haifa, Israel. The investment is about $30 million, the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Frutarom-expands-production-capacity-builds-R-and-D-center-in-Israel_47017.html
October 16, 2012
Avantor Performance Materials (Center Valley, PA) has signed a collaboration agreement with Rubicon Research (Mumbai) to develop, manufacture, and market products for the functional...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Avantor-signs-development-agreement-with-Rubicon-Research-for-pharma-excipients_47016.html
October 16, 2012
Dr. Reddy’s Laboratories (Hyderabad, India), the second largest API company in the world in terms of sales, after Teva, says that it will open a new large-scale active...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/CPhI-Dr-Reddys-builds-large-scale-API-facility-in-India_46975.html
October 16, 2012
Saltigo shuts US site Saltigo (Langenfeld, Germany), a Lanxess subsidiary, says it has discontinued production at the company’s Redmond, WA, site and that it has abandoned a...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-16-October_47001.html
October 15, 2012
DSM Sinochem Pharmaceuticals (DSP; Singapore), the former DSM Anti-Infectives business, says that it is planning to build production capacity for manufacturing the active...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/CPhI-DSM-Sinochem-Pharmaceuticals-to-build-Atorvastatin-facility-in-India_46973.html
October 15, 2012
Aesica Pharmaceuticals (Newcastle, UK), a provider of active pharmaceutical ingredients (APIs), formulations, and custom synthesis, says that it plans to triple annual revenues from...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/CPhI-Aesica-to-triple-API-sales-in-three-years-to-acquire-assets-in-North-America-and-India-next-year_46883.html
October 12, 2012
Saltigo (Langenfeld, Germany), a Lanxess subsidiary, says it has discontinued production at the company’s Redmond, WA, site and that it has abandoned a previously announced...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/CPhI-Saltigo-shuts-US-site-abandons-plans-to-build-potent-API-capacity_46888.html
October 10, 2012
Novasep (Pompey, France) announced at the CPhI trade fair at Madrid that it will invest €30 million ($39 million) to build the world’s largest chromatography plant for the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Novasep-to-build-worlds-largest-chromatography-plant-in-France_46851.html
October 10, 2012
Codexis (Redwood City, CA), a company that develops industrial enzymes to enable the production of pharmaceuticals, biofuels, and biobased chemicals, says that it continues to...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/CPhI-Codexis-focuses-on-innovator-companies_46819.html
October 9, 2012
Active pharmaceutical ingredients (API) manufacturer Hovione (Loures, Portugal) says that it expects the drug product business to be the growth driver for Hovione post 2015, and that...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/CPhI-Drug-product-manufacturing-business-to-drive-growth-for-Hovione_46843.html
October 9, 2012
The US FDA did a good job of implementing the Generic Drug User Fee Act (GDUFA), but has disappointed as far as the falsified medicines directive (FMD) of the European Union (EU) is...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/EFCG-at-CPhI-FDA-did-well-to-implement-GDUFA-but-disappoints-with-FMD-_46844.html
October 9, 2012
Tessenderlo Group said today that it intends to sell its pharmaceutical ingredients activities Farchemia and Calaire Chimie to International Chemical Investors Group (ICIG; Frankfurt)...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Tessenderlo-Group-sells-pharma-ingredients-business-to-International-Chemical-Investors_46813.html
October 4, 2012
Sigma-Aldrich Fine Chemicals (SAFC; St. Louis, MO), a life science company, plans to expand its Scotland operations with the development of a new powder manufacturing facility at its...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Sigma-Aldrich-Begins-Construction-of-Powder-Manufacturing-Facility-at-U-K-Site_46581.html
October 3, 2012
Pharmaceutical company Daiichi Sankyo (Tokyo) says it has decided to reorganize three of its supply chain subsidiaries in Japan – Daiichi Sankyo Propharma (DSPP; Tokyo), Daiichi...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Daiichi-Sankyo-to-restructure-pharma-ingredient-subsidiaries_46639.html
October 3, 2012
Cedarburg Hauser Pharmaceuticals (CHP; Grafton, WI) says it has expanded the capacity of its active pharmaceutical ingredient (API) manufacturing plant in Wisconsin. CHP is a contract...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cedarburg-Hauser-Expands-API-Production-Capacity_46548.html
October 3, 2012
BASF says it will relocate the global headquarters of the pharma ingredients and services business unit from Evionnaz, Switzerland, to Florham Park, NJ. The company has also...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/BASF-to-move-pharma-ingredients-headquarters-to-US-appoints-new-business-head_46597.html
October 2, 2012
BASF to move pharma ingredients headquarters to US, appoints new business head BASF says it will relocate the global headquarters of the pharma ingredients and services business unit...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-October-2_46641.html
October 2, 2012
Mitsubishi Gas Chemical (MGC) says it will stop the manufacture and sale of coenzyme Q10, a material for pharmaceuticals and health food, due to poor profitability of the business...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Mitsubishi-Gas-Chemical-exits-coenzyme-Q10-business_46634.html
October 1, 2012
Ashland says it will open a new pharmaceutical application laboratory at Düsseldorf in December 2012. The laboratory will provide technical support to Ashland’s European...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ashland-to-open-pharmaceutical-lab-in-Germany_46593.html
September 27, 2012
The European Commission has made two proposals to close loopholes in current European Union (EU) legislation on precursors for the illegal drugs methamphetamine and heroin. The...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/EU-Commission-Proposes-Tighter-Controls-on-Precursors-for-Illegal-Drugs_46550.html
Pages: « Previous  7 8 9 10 11 12 13 14 15 [16] 17 18 19 20 21 22 23 24 25 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa